Quick answer

Vanta and Drata are compliance automation platforms, and they are very good at what they do. They were built for SOC 2 and the technology companies that need it, and both now offer a HIPAA module among many frameworks. For a digital health company selling to enterprise customers, they fit well. For a small medical or dental practice, they are the wrong tool at the wrong price. And for any healthcare organization, they share one hard limit: they do not perform the HIPAA Risk Analysis required under 45 CFR 164.308(a)(1)(ii)(A), and they do not sign your business associate agreements. Those are still your job.

I get asked about these two platforms often, usually by a healthcare founder who saw a competitor’s trust badge and wondered if Vanta or Drata is the answer to HIPAA. Sometimes it is. Often it is not. Here is how to tell the difference.

What do Vanta and Drata actually do?

Both are compliance automation tools. They connect to your cloud, identity, and device systems, pull evidence automatically, and run continuous checks against a framework’s controls. Vanta describes automating evidence collection with continuous testing across SOC 2, HIPAA, ISO 27001, PCI, and GDPR, monitoring hundreds of integrations and translating requirements into prescriptive controls and policies. Drata works the same way across more than a dozen frameworks, with automated evidence collection, policy management, vendor risk tracking, and security training in one dashboard.

The value is real. If you have a sprawling cloud environment and you are chasing a security certification, automating evidence collection saves months. The platforms shine at turning a one-time audit scramble into a year-round, monitored state. That is the job they were designed for.

The thing to understand is what kind of compliance that is. SOC 2 is a voluntary attestation that enterprise buyers ask for. HIPAA is a federal law enforced by the Office for Civil Rights. The platforms were architected around the first one, and HIPAA was added as another framework to map. That design choice shapes everything about who they fit.

When do Vanta and Drata fit a healthcare company?

There is a clear case where these tools are a strong choice. You are a digital health or health-tech company. You sell software or a service to hospitals, payers, or other businesses. Those customers will not sign until you can show both a SOC 2 report and HIPAA alignment. You run on cloud infrastructure with dozens of integrations, you have an engineering team, and you have the headcount and budget that match enterprise software pricing.

In that situation, Vanta or Drata earns its cost. You genuinely need multiple frameworks, the continuous monitoring maps to how your systems actually work, and the automation replaces work that would otherwise eat your team. Vanta’s own customer base reflects this. Its users skew heavily toward software and technology companies, not clinical providers. These are tools for healthcare businesses that look like tech companies, because that is who they were built for.

When are they the wrong tool for a small practice?

Now the other case, which is the more common one in my world. You run a small medical, dental, or therapy practice. You are a covered entity. Your patient data lives in a practice management system and an imaging server, not a custom cloud stack. Your real exposure is a missing Risk Analysis, untrained staff, missing business associate agreements, and a breach plan you have never written.

A platform built to automate SOC 2 evidence across cloud integrations does not solve that. You do not have the integration sprawl it is designed to monitor. You do not need SOC 2 at all. And the price is set for a funded company, not a five-person office. Reported 2026 pricing for Vanta runs from about $10,000 to $80,000 a year, and Drata’s tiers reportedly start around $7,500 and climb past $100,000, both custom-quoted. For a small practice, that is a large annual bill for a tool aimed at someone else’s problem.

The mistake is buying the software and believing the patient data work is now handled. It is not. You have bought a very capable filing cabinet for a tech company and you are still missing the documents that go in it.

Do these tools replace your HIPAA Risk Analysis?

No, and this is the part that matters most regardless of your size. The foundation of HIPAA’s Security Rule is the Risk Analysis required under 45 CFR 164.308(a)(1)(ii)(A). It has to be an accurate, thorough, organization-wide look at where your patient data lives and what could go wrong with it. According to HHS guidance on risk analysis, it is a required first step, and inadequate risk analysis appears in roughly 90 percent of OCR’s Security Rule enforcement actions.

Compliance automation does not perform that analysis. It maps controls and collects evidence, which is a different thing. Drata’s own materials make the point plainly: business associates must conduct and document a risk analysis as a separate, required activity that the platform can help organize but does not eliminate. The same is true of your business associate agreements. Every vendor that touches PHI needs a signed BAA under 45 CFR 164.502(e), and no software signs those for you.

The enforcement reality backs this up. On June 18, 2026, OCR settled a ransomware case with an employer health plan for $450,000, and the cited failure was the missing risk analysis. Civil penalties in 2026 run from $145 to $2,190,294 per violation under Federal Register 2026-01688. A dashboard full of green checkmarks is not a defense if the underlying analysis was never done.

So which one do you need?

Match the tool to the actual problem. If you are a health-tech company that needs SOC 2 and HIPAA to sell, look hard at Vanta or Drata, and budget for them as the enterprise software they are. If HIPAA is your only real requirement and you run a clinical practice, a SOC 2 automation platform is not your answer. You need the Risk Analysis done, your BAAs collected, your staff trained, and a breach plan in place. That is consulting work and process, not a monitoring subscription.

Either way, the Risk Analysis comes first, because it tells you what to fix before you spend on any tool to maintain it.

What to do next

If you are not sure which camp you are in, start with the question of what you are actually required to do, not which software has the nicer dashboard. For a clinical practice, that means a documented HIPAA Risk Analysis, which is the work behind our HIPAA Risk Analysis service. If you want a fast read on where you stand, the $750 Privacy Exposure Review gives you your top three risks in 48 hours. For a closer look at why software alone falls short, we covered what a $39 a month HIPAA tool gets you.

Buy the tool that fits your problem. For most small practices, the problem is the analysis, and no platform does that part for you.

Last Updated: June 29, 2026